Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-16-093830)

Filing Details

Accession Number:: 0001209191-16-093830
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-01-27 17:10:20
Reporting Period:: 2016-01-26

Filing Date:: 2016-01-27
Accepted Time:: 2016-01-27 17:10:20
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1346830	Cara Therapeutics Inc.	CARA	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1297065	E Michael Lewis	C/O Cara Therapeutics, Inc. 1 Parrott Drive Shelton CT 06434	Chief Scientific Advisor	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2016-01-26	7,262	$10.93	314,988	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2015.